CALQUENCE 100 MG Oral Tablet

RxCUI: 2607737
RxNorm name: CALQUENCE 100 MG Oral Tablet
Display name: CALQUENCE 100 MG Oral Tablet
Full name: CALQUENCE 100 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CALQUENCE	ACALABRUTINIB	AstraZeneca Pharmaceuticals LP	b1409184-3267-4d8c-8f17-4e01f69828b1	2026-02-19	Warnings, Adverse reactions	Exact identifier rxcui: 2607737

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
b1409184-3267-4d8c-8f17-4e01f69828b1	CALQUENCE 100 MG Oral Tablet [PSN] · acalabrutinib 100 MG Oral Tablet [Calquence] [SBD] · Calquence 100 MG Oral Tablet [SY]	3	8	These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) tablets, for oral use Initial U.S. Approval: 2017	20260219